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A B S T R A C T
Background: Cerebellar Ataxias are a group of gait disorders resulting from dysfunction of the cerebellum,
commonly characterised by slowly progressing incoordination that manifests as problems with balance and
walking leading to considerable disability. There is increasing acceptance of gait analysis techniques to quantify
subtle gait characteristics that are unmeasurable by current clinical methods This systematic review aims to
identify the gait characteristics able to diﬀerentiate between Cerebellar Ataxia and healthy controls.
Methods: Following systematic search and critical appraisal of the literature, gait data relating to preferred
paced walking in Cerebellar Ataxia was extracted from 21 studies. A random-eﬀect model meta-analysis was
performed for 14 spatiotemporal parameters. Quality assessment was completed to detect risk of bias.
Results: There is strong evidence that compared with healthy controls, Cerebellar Ataxia patients walk with a
reduced walking speed and cadence, reduced step length, stride length, and swing phase, increased walking base
width, stride time, step time, stance phase and double limb support phase with increased variability of step
length, stride length, and stride time.
Conclusion: The consensus description provided here, clariﬁes the gait pattern associated with ataxic gait dis-
turbance in a large cohort of participants. High quality research and reporting is needed to explore speciﬁc
genetic diagnoses and identify biomarkers for disease progression in order to develop well-evidenced clinical
guidelines and interventions for Cerebellar Ataxia.
1. Introduction
Cerebellar Ataxias are a group of gait disorders resulting from
dysfunction of the cerebellum and associated systems due to inherited
and acquired causes. Cerebellar Ataxia (CA) is commonly characterised
by slowly progressing incoordination which manifests as problems with
balance and walking leading to considerable disability. Cerebellar
Ataxias aﬀect more than 10,000 adults in the UK [1], with variable age
of onset and disease course.
Gait refers to the cyclic nature in which an individual walks, and is
punctuated by consecutive heel strikes. An individual’s body type,
dictated by their sex, age and any natural physical asymmetries, aﬀects
their unique movement pattern [2]. Gait ataxia is clinically re-
cognisable as a wide-based stance with truncal instability and irregular
lurching steps, which can result in an increased risk of falls [3]. This can
be accompanied or predominated by other symptoms depending on the
ataxia subtype [4].
Presently, the principle methods of gait assessment in a clinical
setting are through use of subjective rating scales such as the Scale for
the Rating and Assessment of Ataxia (SARA) [5]. Although many of
these are validated to detect progression of ataxia [6,7], there is evi-
dence to suggest that clinical assessment scales might underestimate the
severity of gait changes in CA [8].
Instrumented gait analysis techniques quantify subtle gait char-
acteristics that would not be detected by clinical examination. There is
increasing acceptance of the use of gait analysis methods such as 3D
motion capture, pressure-sensitive walkways and inertial sensors for the
assessment of neurological diseases that manifest with gait changes.
Improved classiﬁcation of ataxic gait disturbance and deﬁnition of
biomarkers for disease progression will enable quantiﬁcation of the
eﬀect of novel and existing interventions to improve disease manage-
ment in Cerebellar Ataxia while also clarifying the disease mechanisms
in speciﬁc Cerebellar Ataxia subtypes [9].
Early studies using instrumented gait analysis in individuals with
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cerebellar syndromes described the spatiotemporal gait characteristics
of Cerebellar Ataxia as: reduced cadence, step and length, gait velocity,
and increased step and stride time and stance and swing phases [4,10].
However, other studies provide conﬂicting results and many report
inconsistencies within cohorts. There are currently no guidelines to
state the clinically relevant change in gait characteristics.
With technological advances making it quicker and easier to im-
plement gait analysis, studies exploring neurological gait disorders are
becoming more prevalent. It is now possible to seek a consensus de-
scription of the gait characteristics of Cerebellar Ataxia to explore the
inconsistencies between published studies and to guide further re-
search.
By evaluating and summarising the spatiotemporal gait character-
istic measured using instrumented gait analysis techniques, this sys-
tematic review aims to answer the question: Which gait characteristics
are able to diﬀerentiate between Cerebellar Ataxia and controls?
2. Methods
Available literature was systematically searched, following a pre-
determined protocol (PROSPERO 2016: CRD42016042149, Available
from http://www.crd.york.ac.uk/PROSPERO/display_record.asp?ID=
CRD42016042149).
Using the PICOS framework [11] the research question was ex-
plored in order to guide design of search strategy and selection criteria.
Of interest were studies where straight lined self-paced walking was
measured in adults (age 18yrs or older) with Cerebellar Ataxia. Quan-
tiﬁcation of gait should involve instrumented techniques. Participants
were not required to undergo any type of intervention as baseline gait
characteristics were of most interest. Where healthy controls were re-
cruited they should be matched for age and gender as a minimum.
Studies of all designs were considered, except review articles, if pub-
lished since 1996 and available in English.
2.1. Search strategy
The search strategy and selection criteria were developed in line
with the review questions and agreed on by two researchers (AM, EB).
Titles and abstracts of articles within a number of electronic databases
(MEDLINE via OVID, psyc-INFO via OVID, PubMed, IEEE-xplore,
Cochrane trials library, web of science core collections, and Scopus)
were searched systematically implementing MESH search terms and
key words where appropriate to combine three search phrases (walking
terms (Walk* or gait or Locomotion); measurement terms (Measur* OR
assess* OR evaluat* OR examin* OR analysis OR analy*e OR
Biomechanic OR kinematic OR instrumented) and ataxia terms
(Cerebellar Ataxia OR gait ataxia)) (Supplementary material 1).
Searches were completed in July 2016; repeated in November 2016;
and the output restricted to those published since 1996 until the search
date. Reference lists from eligible articles as well as relevant reviews
and systematic reviews were hand searched and studies identiﬁed
subjected to the same selection criteria. This aimed to reduce any re-
strictions of the search strategy in uncovering unpublished and pub-
lished evidence. Records identiﬁed were imported into EndNote
(Clarivate Analytics); and processed to remove duplicate records and
any older articles that remained.
2.2. Study screening process
Article screening was guided by an Inclusion/Exclusion criteria, pre-
deﬁned in line with the research question (Supplementary material 2).
Titles and abstracts of articles identiﬁed by searches were subjected to
the selection criteria by two researchers independently. References
were divided between assessors in the interest of time, while 10% of
articles were dual-screened to conﬁrm appropriate decision-making and
adherence to the selection criteria.
Those articles that satisﬁed the screening criteria moved on to full
text appraisal. This was completed in parallel by assessors and ﬁnal
selections made through discussion. Where articles were suspected or
conﬁrmed to report results from identical or overlapping cohorts of
patients the earliest or most relevant article was selected for inclusion.
2.3. Data extraction
Study information and gait parameters were extracted from the
selected articles and, where necessary, authors contacted to request
additional results. All available study information and reported gait
characteristics was collated in Microsoft Excel.
Results were converted to common units of measurement, so that all
spatial parameters were expressed in terms of metres (m) and temporal
parameters expressed in terms of seconds (s). Speed was expressed as
metres per second (m/s), cadence as number of steps in a minute
(steps/ min) while phases of the gait cycle were expressed as a per-
centage of the total stride duration (%). Gait variability was reported as
either Coeﬃcient of Variation ((CV) deﬁned as Standard Deviation
(SD)/mean (%)) or combined Standard Deviation ((cSD) deﬁned as the
square root of the mean variance of the left and right steps (cm)) [12].
Where necessary, authors of selected articles were contacted to
clarify study details and obtain unreported results. This included re-
questing mean average and standard deviation of cohort gait char-
acteristics where median and interquartile range was reported and
coeﬃcient of variation where other variability measures (such as
combined standard deviation) were reported. Articles where informa-
tion was not made available for assessment following repeated requests
were excluded from further analysis despite being potentially relevant
studies. Where multiple subgroups were examined in a single study,
data were combined to a single result following Cochrane Review
guidance [11].
2.4. Data synthesis & meta-analysis
For cohort demographics, descriptive statistics (mean average,
standard deviation (SD) and range) will be computed using IBM SPSS
Statistics for Windows, version 23 (IBM Corp., Armonk, N.Y., USA)
Meta-analysis was completed in Rstudio (version 3.3.2) [13], using
the “meta” package [14]. For parameters where results were available
for more than 3 studies, the weighted mean diﬀerence (MD), 95%
Conﬁdence intervals (CI) and the standardised Z-score for overall eﬀect
were computed. Heterogeneity was tested using I2 statistic, although a
single group random eﬀect model (REM) used throughout to give a
conservative approach to meta-analysis.
Forest plots were generated to display the comparison of walking
gait characteristics in Cerebellar Ataxia and healthy controls from
preferred/comfortable self-paced walking.
Studies without control cohorts were included in the meta-analysis
but not given any weighting in the calculation of the pooled estimate.
To ensure the uniformity of data processing, gait parameters that had
been standardised for individual biomechanical features (e.g. leg length
or height), were excluded from meta-analyses. For gait variability, only
coeﬃcient of variation was reported commonly enough for results to be
meta-analysed.
2.5. Quality assessment
Studies that were eligible for inclusion underwent quality assess-
ment to detect risk of bias using an adaptation of the criteria described
by Littell et al. [15] (Supplementary material 3). Researcher’s in-
dependent ﬁndings were compared, and ratings were agreed on
through discussion.
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3. Results
3.1. Study selection
In total, 1363 records were identiﬁed through searches of 6 data-
bases and numerous reference lists (Supplementary material 4). Of the
65 records that were screened as full texts, 21 articles [10,16–35] were
selected for data extraction. Due to issues of data availability, 3 articles
[20,21,25] were excluded from the meta-analysis.
3.2. Critical appraisal
A summary of the 21 included articles [10,16–35] is displayed in
Supplementary material 5. Combined, these reﬂect gait assessments for
408 patients with established Cerebellar Ataxia and 403 healthy con-
trols, with 44.12% and 48.14% females respectively (Supplementary
material 6). Although only 16 articles had control cohorts, controls
were always matched to the patient cohort’s age and gender. Height
and weight were also matched when reported. These clinical studies
were completed across 10 countries (9 developed and 1 developing).
Patient cohorts were very often of mixed aetiology, but most (17)
stated the speciﬁc diagnoses reﬂected in the group. Gait characteristics
of more speciﬁc ataxia types were explored in 8 studies
[17,18,20,24,26,27,30–32] encompassing Chromosome 16q-linked
Autosomal Dominant Cerebellar Ataxia (16q-ADCA), Spinocerebellar
Ataxias (SCA1/2/6/14), cerebellar subtype Multiple System Atrophy
(MSAc), and Friedreich Ataxia (FRDA). Findings from these studies
included: a correlation between plantar pressures and Double Limb
Support phase (DLS) in SCA6 compared with MSAc and 16q-ADCA
groups [18], a greater improvement with rehabilitative training in CA
than aﬀerent forms of ataxia [20] and a longer step length measured in
individuals with SCA1/2 than with FRDA [30].
Twenty of the records included, related to published articles, ac-
companied by one conference abstract. This group of articles contains 2
intervention studies that explored the impact of rehabilitation and
training on ataxic gait and 17 prospective observational studies in-
vestigating speciﬁc gait features of ataxic gait or validating new clinical
tools and methods of analysis.
Follow-up assessments were completed in 4 studies, of which two
were training studies [19,21] and the third incorporated data as in-
dependent samples [17]. The remaining study [23], performed a follow
up assessment at 6 months on a subset of the initial cohort (n = 11/51)
and identiﬁed no signiﬁcant diﬀerence in velocity (the only spatio-
temporal parameter reported).
Disease symptoms and balance/gait deﬁcits were rated using clin-
ical rating scales in 17 studies. Most commonly, International
Cooperative Ataxia Rating Scale (ICARS) [36] or Scale for the Assess-
ment and Rating of Ataxia (SARA) [5] were implemented, with 8 other
rating scales used in the included studies. The ICARS and SARA scores
reported conﬁrm that patients included here showed gait diﬃculties
but were still capable of independent walking [5,37]. Use of walking
aids was expressly excluded in 14 studies while 11 studies excluded
individuals with cognitive dysfunction.
Falls occurrence was reported in just 3 studies [26,28,34] where a
higher rate of falls was apparent, with 43.18% (38/88) of those patients
reported falling with the last 3–12months. Between these studies, only
Schniepp et al. performed analysis exploring gait metrics associated
with fall status [28]. They reported that a history of falls is associated
with an increased stride length variability and stride time variability
which correlates with preferred walking speed.
To track spatiotemporal characteristics of walking, the most com-
monly implemented gait analysis techniques within these studies were
3D Motion Capture, employed in 9 studies, and Pressure Sensitive
Walkways, used in 8 studies. Other techniques used were: triaxial in-
ertial sensors, pressure sensitive insoles, force plates and pressure sen-
sitive treadmill. Within the included studies, all participants completed
comparable short gait tasks to assess free unassisted, straight-line, self-
determined speed walking in a laboratory setting. Walkway length for
diﬀerent studies was between 2.2 m and 20 m
(mean ± SD= 9.1 m ± 3.4 m) and was principally controlled by the
equipment type used. Participants walked barefoot in each of the 9
studies where 3D motion capture was used.
Eight studies explored the inﬂuence of pace on gait, through trials
performed at diﬀerent walking speeds. Diﬀerent velocity walking trials
were executed in 7 studies [5,16,21,22,24,28,31,32]. Participants
within these studies completed walking tasks at a range of speeds be-
tween very slow and very fast. Upon full text appraisal, fast-paced
walking by patients with ataxia was consistently associated with in-
creased cadence, step and stride length, and swing phase as well as
decreased in the stance and DLS phases, compared with preferred- and
slow-paced walking. Meanwhile, variability of stride time and stride
length, shows a U-shaped curve with the minimal CV magnitude ob-
served in preferred paced walking and highest CV magnitude detected
in slow paced walking [28,32].
Although 42 gait parameters were identiﬁed, only 14 were reported
frequently enough to be explored further through meta-analysis. A
summary of cohort mean values for gait metrics can be seen in Table 1.
3.3. Quality assessment
Upon quality assessment, 10 articles were rated “good” with low
risk of bias, 10 rated “fair” with some risk of bias (Supplementary
material 7). None were deemed to be of “poor” quality and at too high
risk of bias for inclusion, but insuﬃcient data was available from one
study [25] to reach a full rating. All the published articles clearly stated
appropriate research questions and hypotheses, participant inclusion
criteria, gait analysis protocols and study ﬁndings.
Most (15) of the articles adjusted for confounding variables such as
gait speed, or morphological features. Meanwhile, none of the articles
provided a power calculation to justify the small cohort sizes.
3.4. Meta-analysis results
The included articles reported several distinct spatiotemporal gait
characteristics measured during walking at a self-selected pace. A
summary of each study’s mean average and standard deviation of gait
characteristics outcome with units displayed in Supplementary material
8.
Meta-analysis was completed for 14 spatiotemporal gait parameters
extracted from 18 primary studies. Other parameters lacked suﬃcient
evidence to assess between cohort diﬀerences. Exclusion of results
standardised to leg length or height led to some data being excluded
from meta-analysis.
3.4.1. Pace
Walking speed was studied by 14 studies
[10,16,17,19,23,24,26–33] and in ataxia (n = 281) preferred walking
speed was signiﬁcantly reduced compared with healthy controls
(n = 345) (REM, MD=−0.36 m/s, 95% CI (−0.43, −0.29),
p < 0.01, I2 = 0%) (Fig. 1a). Similarly, in the 10 studies that reported
cadence (number of steps per min) [10,16–18,23,24,26–28,31] the
ataxia cohort (n = 208) demonstrated signiﬁcantly reduced cadence
than healthy controls (n = 267) (REM, MD=−13.28 steps/min, 95%
CI (−19.99, −6.58), p < 0.01, I2 = 99%) (Fig. 1b).
3.4.2. Spatial
Step length, was studied by 7 studies [17,19,23,26,30,31,33] and
was signiﬁcantly reduced in ataxia cohort (n = 139) compared to
healthy controls (n = 251) (−0.14 m (−0.20, −0.08), p < 0.01,
I2 = 0%) (Fig. 2a). Stride length was also signiﬁcantly reduced in ataxia
(n = 94) compared to healthy controls (n = 142) (REM,
MD=−0.20 m, 95% CI (−0.36, −0.04), p = 0.01, I2 = 0%) as
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reported by 5 studies [17,24,28,31,32] (Fig. 2b). Meanwhile, walking
base width was studied by 10 studies [17–19,24,26–30,32,33] and
people with ataxia (n = 192) demonstrated signiﬁcantly increased
walking base width compared with healthy controls (n = 241) (REM,
MD=−0.06 m, 95% CI (0.02, 0.10), p < 0.01, I2 = 0%) (Fig. 2c).
3.4.3. Temporal
As reported by 3 studies [10,17,26], step time is signiﬁcantly
Table 1
Summary of Gait Characteristics.
See Supplementary material 4 for gait analysis results from each study. N = number of participants, k = number of articles featured in, results reported as mean average ± standard
deviation (SD) (range).
Cases Controls
N Mean Average ± SD K N Mean Average ± SD K P value
Pace
Speed (m/s) 281 0.91± 0.16 14 345 1.27 ± 0.15 12 <0.01
Cadence (steps/min) 208 98.68 ± 10.85 10 267 111.97 ± 6.71 8 <0.01
Spatial
Step Length (m) 139 0.54 ± 0.09 7 251 0.68 ± 0.06 7 <0.01
Stride Length (m) 94 1.17 ± 0.01 5 142 1.37 ± 0.04 3 0.01
Base Width (m) 192 0.17 ± 0.04 10 241 0.11 ± 0.03 8 <0.01
Temporal
Step Time (s) 42 0.63 ± 0.01 3 158 0.51 ± 0.02 3 0.01
Stride Time (s) 120 1.21 ± 0.06 7 177 1.03 ± 0.04 6 <0.01
Gait Cycle
Swing Phase (% cycle) 54 33.92 ± 3.44 4 146 39.25 ± 0.14 3 <0.01
Stance Phase (% cycle) 57 65.99 ± 2.78 4 161 60.55 ± 0.22 4 <0.01
Double Limb Support Phase (% cycle) 126 22.50 ± 6.77 7 170 16.76 ± 7.26 5 <0.01
Variability
Step Length Variability (%CV) 78 8.96 ± 1.94 5 184 3.07 ± 0.71 5 <0.01
Stride Length Variability (%CV) 80 6.82 ± 1.70 4 142 1.95 ± 0.24 3 <0.01
Stride Time Variability (%CV) 116 5.54 ± 1.05 6 187 2.24 ± 0.36 5 <0.01
Speed Variability (%CV) 40 7.68 ± 4.31 3 148 3.46 ± 0.49 3 0.20
Fig. 1. Pace Domain. Mean diﬀerence in a) speed (m/s) and b) cadence (steps per min) during self-selected pace walking.
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increased in ataxia (n = 42), compared with healthy controls
(n = 158) (REM, MD= 0.11s, 95% CI (0.03, 0.20), p = 0.01, I2 = 0%)
(Fig. 3a). Stride time was studied by 7 studies [10,17,19,27,28,30,32]
and overall, the ataxia cohort (n = 120) demonstrated signiﬁcantly
increased stride time than healthy controls (n = 177) (REM,
MD= 0.18s, 95% CI (0.08, 0.27), p < 0.01, I2 = 0%) (Fig. 3b).
3.4.4. Gait cycle
The swing phase of the gait cycle was explored by 4 studies
[17,24,31,33]. People with ataxia (n = 54) exhibited a signiﬁcantly
reduced swing phase duration than healthy controls (n = 146) (REM,
MD=−5.33%, 95% CI (−9.18, −1.43), p < 0.01, I2 = 97%)
(Fig. 4a). Meanwhile stance phase duration was signiﬁcantly increased
in the ataxia cohort (n = 57) than in healthy controls (n = 161) (REM,
MD= 5.44%, 95% CI (2.12, 8.76), p < 0.01, I2 = 97%) as reported
by 4 studies [17,30,31,33] (Fig. 4b). Double limb support phase was
studied by 7 studies [17,24,27,28,30,31,33] and the ataxia cohort
(n = 126) demonstrated signiﬁcantly increased double limb support
phase duration than controls (n = 170) (REM, MD= 5.74%, 95% CI
(3.81, 7.68), p < 0.01, I2 = 93%) (Fig. 4c).
3.4.5. Variability
As shown in Fig. 5a, variability of step length was investigated by 5
studies [10,16–18,30]. The ataxia cohort (n = 78) demonstrated sig-
niﬁcantly increased step length variability compared to controls
(n = 184) (REM, MD= 5.88%CV, 95% CI (3.42, 8.34), p < 0.01,
I2 = 97%). Meanwhile, variability of stride length was also sig-
niﬁcantly increased in people with ataxia (n = 80) compared to healthy
controls (n = 142) (REM, MD= 4.87%CV, 95% CI (2.29, 7.45),
p < 0.01, I2 = 95%) [10,17,27,28] (Fig. 5b). Variability of stride time
was considered by 6 studies [10,16,17,27,28,30], conﬁrming a sig-
niﬁcant increase in ataxia (n = 116) compared with healthy controls
(n = 187) (REM, MD= 3.17%CV, 95% CI (1.97. 4.37), p < 0.01,
I2 = 91%) (Fig. 5c).
4. Discussion
This systematic review objectively evaluated the existing evidence
base for the gait characteristics of adult Cerebellar Ataxia. The 21 in-
cluded studies reﬂect quantitative gait assessments for 408 Cerebellar
Ataxia patients and 403 healthy controls. This forms a larger cohort
than typically available in an individual descriptive study. Each in-
dividual study conﬁrmed that cohort demographics (age, gender,
height, leg length and Body Mass Index (BMI)) were equivalent and no
signiﬁcant diﬀerences between cases and control characteristics are
present in the meta-analysis.
Fig. 2. Spatial Domain. Mean diﬀerence in a) step length (cm), b) stride length (cm) and c) base width (cm) during self-selected pace walking.
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4.1. Headline results
During preferred paced walking, there is strong evidence that
Cerebellar Ataxia patients display the following gait diﬀerences against
healthy controls:
• reduced walking speed and cadence
• reduced step length, stride length, and swing phase
• increased base width, stride time, step time, stance phase and
double limb support phase
• increased variability of step length, stride length, and stride time.
Fig. 3. Temporal Domain. Mean diﬀerence in a) step time (s) and b) stride time (s) during self-selected pace walking.
Fig. 4. Gait Cycle Domain. Mean diﬀerence in a) swing phase (%), b) stance phase (%) and c) Double Limb Support (DLS) phase (%) during self-selected paced walking.
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These adjustments were signiﬁcantly diﬀerent (p < 0.01) and
consistently associated with a z-score greater than the 95% critical z-
score (1.96). The gait parameters that were greatest aﬀected in
Cerebellar Ataxia (in terms of z-score) were Speed, Double Limb
Support phase duration (%cycle) and stride time variability followed by
Step Length Variability and Step Length. Although this suggests that
these may be most useful in clinical practice, further research is ne-
cessary to consider a number of contributing factors.
4.2. Implications for practice/Future studies
Our ﬁndings corroborate reports that in ataxia gait modiﬁcations
are employed to compensate for incoordination and trunk instability
[38], possibly to reduce the falls risk common to these patients. Re-
duced velocity of self-selected walking and increased sagittal gait
variability [28], as well as widened gait [34] correlate with risk of falls.
It is thought that while increased gait variability directly reﬂects the
dynamic imbalance in Cerebellar Ataxia and is related to the presence
of cerebellar damage [30,39], the increased step width, and decreased
step length are compensations for trunk instability [30,40].
Although upper body metrics were reported in a minority of studies,
there is evidence to indicate that exaggerations in trunk ﬂexion-ex-
tension and an increased trunk rotation are present in cerebellar ataxia
to increase stability [35]. In this way gait velocity and spatiotemporal
parameters are preserved and maintain an energy eﬃcient gait. In
cerebellar ataxia, patients display increased trunk instability in all 3
directions but the anterior-posterior direction particularly [3,23,34].
While the overall instability correlates negatively with ICARS score,
and positively with disease stage, this anterior-posterior instability may
contribute to fall direction [41].
A number of articles report that in ataxia, walking at preferred
speed minimises the gait abnormalities and recommend analysis of gait
at a wide range of speeds [32]. However, since subjective rating scales
incorporating self-selected paced walking remain the main method of
Fig. 5. Variability Domain. Mean diﬀerence in a) step length variability (% CV), b) stride length variability (% CV), c) stride time variability (% CV) and d) speed variability (% CV)
during self-selected paced walking.
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clinical gait assessment, our ﬁndings clarify ataxic gait characteristics
as they would appear in a typical assessment.
In ataxia patients, with increasing speed walking, gait is char-
acterised by increased cadence, step and stride length, and swing%
phase as well as decreases in the stance% and DLS% phases [24].
Meanwhile, a nonlinear correlation is reported in stride time variability
and stride length variability, with the highest CV in slow paced
walking, and preferred paced walking associated with the minimal CV
magnitude [28,32].
Many of these speed-dependent gait changes are also observed in
healthy adults [42,43], and are more pronounced with age [44].
However, in controls gait variability is less closely associated with
speed changes to allow ﬂexibility and adaptability of walking strategy
[45]. Although in Multiple Sclerosis [46], fast paced walking is reported
to be more sensitive to gait changes, this complexity makes it less clear
whether fast or slow walking is more clinically sensitive in Cerebellar
Ataxia. It appears that diﬀerent compensation strategies are at play in
fast and slow paced walking. For instance, while more strongly sig-
niﬁcant diﬀerences have been reported in swing, stance and DLS phase
between patients and controls in fast walking, than in preferred paced
walking [31], the increased variability of slow paced walking is cor-
related with to falls risk [28]. However, spatiotemporal parameters of
gait measured in slow paced conditions correlate with a fewer number
of clinical markers than in fast and preferred paced walking [24].
There is also evidence to suggest that gait has potential to distin-
guish between neurological gait disorders, diﬀerentiate forms of
Cerebellar Ataxia and be sensitive to disease progression. For instance,
Parkinson’s Disease and Huntington’s disease, two diseases of the basal
ganglia, are also characterised by decreased stride/step length with a
reduced walking velocity [47] but have a number of diﬀerences from
Cerebellar Ataxia and each other. In Parkinson’s Disease, cadence re-
mains normal, and a linear relationship between stride length and ve-
locity is maintained, comparable to healthy controls [4,16,19]. Mean-
while gait variability is increased compared with healthy controls but
remains lower than in Cerebellar Ataxia [48] although changes to step
width are unclear, (either decreased or unaﬀected). However in man-
ifest Huntington’s disease, an increased step width and even more in-
creased gait variability are apparent while stride time is not sig-
niﬁcantly diﬀerent from Parkinson’s Disease [4,48–50]. However,
although a signiﬁcant increase in width of walking base was found in
the meta-analysis reported here, it has previously been suggested that
stride width may not a disease speciﬁc gait characteristic but a com-
pensation for the instability that occurs in many gait disorders [29].
While it is likely that through objective gait analysis, movement dis-
orders of the basal ganglia can be distinguished from those of cerebellar
origin, it is not possible to appraise speciﬁc changes across diﬀerent
pathologies from the present dataset [47].
Clariﬁcation of the objective diﬀerences between forms of ataxia has
the potential to improve understanding of the underlying disease. While
a number of studies explored the diﬀerences between speciﬁc forms of
cerebellar ataxia there is insuﬃcient evidence to categorically deﬁne
the interaction between disease type and gait changes. However, there
appears to be diﬀerent gait features present between ataxia subtypes
which may relate to the underlying disease diﬀerences, such as patterns
of cerebellar degeneration, the presence of pyramidal signs and disease
duration. This may contribute by aﬀecting components of gait, or the
patient’s ability to apply compensations. Further work is required to
clarify these interactions and their inﬂuence on falls status and link to
clinical markers [24,41].
The studies included here that explored longitudinal gait changes
were not suﬃciently able to provide a conclusive description of gait
disturbances with disease progression. However, follow-up studies to
two others included here have recently been published [51,52]. In
Friedreich Ataxia (FRDA) and mixed CAs, at 2 year and 4 year follow-
up assessments respectively, these also reported reduced gait speed, an
increase in gait variability, cadence and stride length, and step length as
well as reduced swing and increased DLS phases. In comparison with
baseline characteristics, these gait compensations and changes reﬂect
an increase in postural instability with disease progression. Interest-
ingly, these studies also observed that gait variability was able to pre-
dict loss of independent gait, and disease severity (measured by Frie-
dreich's Ataxia Rating Scale (FARS) or SARA) was signiﬁcantly diﬀerent
at follow-up from baseline, FARS scores changes did correlate well with
objective gait characteristics, while SARA scores did not. Due to the
complex nature of these ﬁndings, further assessment of the objective
gait characteristics within a longitudinal study is required to clarify
impact of disease progression on diﬀerent cerebellar ataxia subtypes.
4.3. Strengths & weaknesses
In assessment of the methodological quality, all included studies
were considered suitable, although some limitations were apparent.
Findings should be interpreted in the context of its strengths and
weaknesses.
Many studies considered confounding variables and all completed
concurrent cohort assessments in an appropriate trial protocol for in-
stance walkway lengths were relatively consistent between studies and
mostly considered long enough to analyse a suﬃcient number of steps
collected from steady state gait. Gait metrics were mostly well-deﬁned
and ﬁndings, research questions and inclusion/exclusion criteria were
clearly reported. Study populations were usually well-deﬁned and co-
horts were representative and evenly matched for age, BMI and gender
to restrict their inﬂuence on gait parameters. Patients with non-clini-
cally “pure” ataxia were commonly excluded to avoid involvement of
other neurological systems.
There are several limitations of the included studies that should be
taken into account. Primarily, heterogeneity analysis revealed disparity
between studies in meta-analyses for cadence, Swing (%cycle), Stance
(%cycle), Double Limb Support phase (%cycle), Step length variability,
Stride length variability, Stride time variability and Speed variability,
but large within-study variability in the remaining variables (Speed,
Base width, Stride length, Step length, Step time, Stride time).
The comparative rarity of Cerebellar Ataxia in the general popula-
tion can lead to recruitment diﬃculties in observational clinical studies,
and in fact many of these studies recruited in less than ﬁfteen partici-
pants per cohort (on average, 19.43 (± 11.33) patients and 25.19
(± 29.03) healthy controls in each study). It is essential that studies
report a sample size justiﬁcation and attempt to reach statistical power
where possible in order to reliably determine precise diﬀerences be-
tween cohorts.
Meanwhile, some intervention studies did not assess healthy in-
dividuals as control participants, as might be expected. In addition, a
number of the studies reported results for speciﬁc parameters of interest
and did not consider all possible parameters of gait despite possible
associations.
Many of the patient cohorts were either not fully characterised in
terms of diagnosis or several ataxia subtypes were grouped despite
potential diﬀerences in the ataxia syndrome [53]. Disease severity was
inconsistently characterised with a variety of rating scales employed.
Most of the patients studied completed the walking task unaided, re-
ﬂecting the relatively low disease severity in the cohort. This is a
common problem in gait analysis studies as more severely aﬀected
patients are unable to take part without additional support.
One important consideration is the inﬂuence of technical restric-
tions of equipment on study design, walking protocol and parameter
deﬁnitions. This impacts the length of walkway, whether participants
complete the walking task barefoot and the ability of participants to
reach steady state walking pace and can aﬀect walking characteristics
[54,55]. Also it should be noted that, despite studies validating
equipment and techniques, diﬀerences in analytical approach may af-
fect the results attained.
Unfortunately, due to limitations of the dataset it is not possible to
E. Buckley et al. *DLW	3RVWXUH²

formally explore the inﬂuence of distinct confounding inﬂuences such
as ataxia diagnosis type separately from equipment used, the correla-
tions between upper body and spatiotemporal gait parameters, or the
eﬀect of changing velocity or disease progression on gait character-
istics.
In addition, some articles did not report the full results of gait
parameters analysed, opting to present a combined measure, or sec-
ondary analysis for example, the results of correlation analyses or the
variability of gait parameters. However, several authors made addi-
tional data available for this systematic review.
Due to the heterogeneous nature of clinical studies, these were not
deemed to be fatal ﬂaws but informed restrictions on data included in
meta-analysis. To overcome protocol diﬀerences and the inﬂuence of
changing gait strategies with speed, only spatiotemporal gait char-
acteristics measured using instrumented gait analysis techniques during
preferred-paced straight-line walking in a laboratory setting at baseline
assessment, were considered and standardised data excluded from
meta-analysis.
Meanwhile, it should be considered that in walking gait, many
characteristics are inherently interdependent. Therefore while they
were each considered separately here, step/stride periods, and swing/
stance/DLS phases inevitably contribute to each other [43,56]. Also,
although results were excluded from meta-analysis where for con-
tributing factors such as gait velocity and biomechanical features were
controlled through standardisation, it is important to bear in mind that
these do inﬂuence gait characteristics in the individual.
4.4. Closing statement
This systematic review provides a consensus description of the gait
characteristics of Cerebellar Ataxia in a larger cohort than possible in a
typical descriptive study.
It seems that due to trunk instability, in Cerebellar Ataxia an in-
creased gait variability occurs. To compensate for this, walkers increase
the width of the base of support, take smaller steps and increase the
duration of foot contact to ﬂoor, sacriﬁcing swing phase. They progress
forward slower, with a lower cadence and preferred walking pace. The
signiﬁcant diﬀerences in spatiotemporal parameters uncovered by our
meta-analysis reﬂect the considerable gait disability seen in these pa-
tients compared with healthy controls. These changes lead to an in-
creased risk of falls and have potential as markers of disease progression
due to the sensitivity to progression.
Advances in technology, have enabled gait analysis techniques to be
more widely employed and genetic testing is also more readily available
[57,58]. To accompany this, an increase in the quality of research and
reporting in the future is needed to aid clinical decision making. Key
criticisms such as studies lacking control cohorts, small participant
numbers and speciﬁc genetic diagnoses should be addressed in future
research.
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